LON:CSRT - Consort Medical Share Price, Forecast & News

Consort Medical trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."

Consort Medical announced a dividend on Thursday, June 13th. Shareholders of record on Thursday, September 19th will be paid a dividend of GBX 13.80 per share on Friday, October 25th. This represents a yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 19th. This is an increase from Consort Medical's previous dividend of $7.60. The official announcement can be seen at this link. View Consort Medical's Dividend History.

3 Wall Street analysts have issued 1-year target prices for Consort Medical's stock. Their forecasts range from GBX 1,200 to GBX 1,200. On average, they anticipate Consort Medical's share price to reach GBX 1,200 in the next twelve months. This suggests a possible upside of 14.8% from the stock's current price. View Analyst Price Targets for Consort Medical.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Consort Medical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Consort Medical.

News coverage about CSRT stock has trended somewhat negative this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Consort Medical earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Consort Medical.

Some companies that are related to Consort Medical include Corindus Vascular Robotics (CVRS), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), InspireMD (NSPR), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Consort Medical investors own include Chubb (CB), Newcrest Mining (NCM), Petrel Resources (PET), Resolute Mining (RSG), Premier Investments (PMV), Poydras Gaming Finance (PYD), JD Sports Fashion (JD), Kirkland Lake Gold (KGI), Rambler Metals and Mining (RMM) and People's United Financial (PBCT).

Shares of CSRT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of CSRT stock can currently be purchased for approximately GBX 1,045.

Consort Medical has a market capitalization of £515.86 million and generates £305.10 million in revenue each year. View Additional Information About Consort Medical.

The official website for Consort Medical is http://www.consortmedical.com/.

Consort Medical's mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The company can be reached via phone at +44-1442-867920.